|
发表于 2020-8-8 17:43
来自手机
|显示全部楼层
此文章由 chier819 原创或转贴,不代表本站立场和观点,版权归 oursteps.com.au 和作者 chier819 所有!转贴必须注明作者、出处和本声明,并保持内容完整
hlg0606 发表于 2020-8-8 17:03
现在20万股。
不舍得卖。不过又怕白忙乎一场
哈哈,鸡蛋不要放在同一个篮子里,所以我布局了很多新冠疫情股,比如:PAA、BIT、NOX……说不定哪个出来就是30倍,甚至50倍,比如美国的诺瓦克公司,几个月从5美元飙到170+。DYOR
The search is on across the globe for a vaccine discovery with the potential to arrest the COVID-19 pandemic. There are quite literally dozens of companies who's scientific researches work around the clock to crack the code that will lead them and their shareholders to not only scientific breakthrough, but also to extreme wealth.
One such company is Novavax (NVAX) - the company announced further positive phase 1 data for its COVID-19 vaccine candidate earlier this week sending the world ablaze with positive chatter and its share price hitting new highs again. Just last October 2019 NVAX traded around the 5-00 USD mark - but since has made eye watering gains to finish yesterday the 7th of August 170.29 USD a share.
But we must be realistic, and we must ask ourselves - will a vaccine be all that is needed to bring our world back to some kind of normality? Could sufficient amounts of vaccine be produced in time to save literally millions of lives?
At what cost will the vaccine be made available and will the development and production costs leave the vaccine financially out of reach for many of our elderly and the poor?
The sheer logistics of transporting many hundreds of millions of doses around the globe would be a nightmare in itself, is it even possible?
Many scientists around the world believe that planet Earths human population will need something extra in dealing with this Covid catastrophe. Several of Australia's best scientific brains have also been working tirelessly and investors are starting to pick up the scent of potential huge financial gain.
|
|